Great announcement - but there will be many such required - what may be missing is converting the benefits of earlier diagnosis into a monetary advantage that individuals and institutions will pay for. The big bucks unfortunately comes from rescuing individuals - the system doesn't seem to value prevention (vaccines aside) and so, PIQ will need and influencer to adopt and run with this - perhaps Joe Rogan would like to know if he's a risk DKD ? GLP-1 agonists are all the rage but are destined to be a classic "short term advantage, long term problem" therapy. DKD or most forms of chronic kidney disease is mostly irreversible - best to avoid damage rather than hoping for a therapeutic miracle. Kidney disease, like other organ degenerative diseases, can be relatively silent till well advanced - Promarker D is early warning - this should be embraced by those who look at "at risk populations" that are at greatest risk for early onset KD (which also accelerates atherosclerosis).
PIQ Price at posting:
39.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)